Despite the unique advantage of the isothermal exponential
amplification
reaction (EXPAR) for the rapid detection of short nucleic acids, it
severely suffers from the drawback of sequence-dependent amplification
bias, mainly arising from the secondary structures of the EXPAR template
under the commonly used reaction temperature (55 °C). As such,
the limits of detection (LOD) for different target sequences may vary
considerably from aM to nM. Here we report a sequence-generic exponential
amplification reaction (SG-EXPAR) that eliminates sequence-dependent
amplification bias and achieves similar amplification performance
for different targets with generally sub-fM LODs. The assay innovatively
employs a thermophilic nicking enzyme that allows SG-EXPAR to work
efficiently at higher temperatures (60–70 °C) while eliminating
the secondary structures of the templates, which is the basis for
eliminating the amplification bias. Furthermore, we increased the
probability of trigger/template binding through rational modification
of the locked nucleic acids and template optimization, further ensuring
the high amplification efficiency for various targets. According to
these critical principles, we have developed an automated design platform
that allows nonspecialists to obtain the optimal SG-EXPAR template
for any desired sequence. The robust performance of the proposed methodology
was demonstrated by quantifying microRNA, SARS-CoV-2, monkeypox virus,
and HPV B19 at the 1 fM level without sequence screening. SG-EXPAR
significantly expands the potential applications of EXPAR and facilitates
the development of reliable point-of-care nucleic acid assays.